Label: MAGNESIUM OXIDE tablet

  • Category: DIETARY SUPPLEMENT
  • DEA Schedule: None
  • Marketing Status: Dietary Supplement

Drug Label Information

Updated November 12, 2021

If you are a consumer or patient please visit this version.

View All Sections
  • STATEMENT OF IDENTITY

    Magnesium  (as magnesium oxide) 253mg

    Ingredients

    Microcrystalline Cellulose, Croscarmellose Sodium, Stearic Acid, Colloidal Silicon Dioxide.

  • DIRECTIONS

    As a dietary supplement, adults take one (1) tablet daily preferably with food or as directed by your healthcare practitioner.

  • CAUTIONS

    If you are pregnant, nursing, taking any medications or have any medical condition, consult your doctor before use.

    If you have kidney disease, take only under the supervision of a doctor. Discontinue use and consult your doctor if any adverse reactions occur.

    Keep out of reach of children.

    Store in a cool, dry place

    Tamper

    Do not use if imprinted safety seal under cap is broken or missing.

  • HEALTH CLAIMS

    Take care of your whole body

    Magnesium is essential for supporting bone health, and plays an important role in maintaining bone mineralization*

    As a component in over 200 enzymes in the body, Magnesium is involved in muscle contractions, nerve impulses, energy metabolism and protein formation*

    *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

  • PRINCIPAL DISPLAY PANEL

    Magnesium

    Magnesium


  • INGREDIENTS AND APPEARANCE
    MAGNESIUM OXIDE 
    magnesium oxide tablet
    Product Information
    Product TypeDIETARY SUPPLEMENTItem Code (Source)NHRIC:69168-306
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM OXIDE253 mg
    Inactive Ingredients
    Ingredient NameStrength
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NHRIC:69168-306-8290 in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    DIETARY SUPPLEMENT11/11/2021
    Supplement Facts
    Serving Size : Serving per Container :
    Amount Per Serving% Daily Value
    color
    imprint
    scoring1
    shape
    size (solid drugs)11 mm
    Labeler - Allegiant Health (079501930)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!